Merit Medical Systems Management
Management Kriterienprüfungen 3/4
Merit Medical Systems' CEO ist Fred Lampropoulos , ernannt in Jul 1987, hat eine Amtszeit von 37.08 Jahren. Die jährliche Gesamtvergütung beträgt $10.05M , bestehend aus 18.8% Gehalt und 81.2% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 1.98% der Aktien des Unternehmens, im Wert von $98.09M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 5 Jahre bzw. 4.6 Jahre.
Wichtige Informationen
Fred Lampropoulos
Geschäftsführender
US$10.1m
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | 18.8% |
| Amtszeit als Geschäftsführer | 37.2yrs |
| Eigentum des Geschäftsführers | 2.0% |
| Durchschnittliche Amtszeit des Managements | 5yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 4.7yrs |
Jüngste Management Updates
Recent updates
Merit Medical Systems - Impressive Momentum
Sep 17The Price Is Right For Merit Medical Systems, Inc. (NASDAQ:MMSI)
Sep 17
Why Merit Medical Systems, Inc. (NASDAQ:MMSI) Could Be Worth Watching
Sep 04Merit Medical Systems (NASDAQ:MMSI) Is Doing The Right Things To Multiply Its Share Price
Aug 22These 4 Measures Indicate That Merit Medical Systems (NASDAQ:MMSI) Is Using Debt Safely
Jul 31Merit Medical Systems: Steady Wins The Day
Jul 05Merit Medical Systems (NASDAQ:MMSI) Ticks All The Boxes When It Comes To Earnings Growth
Jun 19Merit Medical: Undervalued With Multiple Growth Drivers In Play
Jun 15Merit Medical Systems (NASDAQ:MMSI) Is Doing The Right Things To Multiply Its Share Price
May 23It Looks Like Shareholders Would Probably Approve Merit Medical Systems, Inc.'s (NASDAQ:MMSI) CEO Compensation Package
May 09Results: Merit Medical Systems, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
May 03Is Merit Medical Systems (NASDAQ:MMSI) Using Too Much Debt?
Apr 30Merit Medical Systems, Inc. (NASDAQ:MMSI) Not Lagging Market On Growth Or Pricing
Apr 16When Should You Buy Merit Medical Systems, Inc. (NASDAQ:MMSI)?
Apr 02Merit Medical Systems: Solid Performer, Fully Valued
Mar 03Analyst Estimates: Here's What Brokers Think Of Merit Medical Systems, Inc. (NASDAQ:MMSI) After Its Full-Year Report
Mar 02We Ran A Stock Scan For Earnings Growth And Merit Medical Systems (NASDAQ:MMSI) Passed With Ease
Feb 05The Returns At Merit Medical Systems (NASDAQ:MMSI) Aren't Growing
Jan 23What You Can Learn From Merit Medical Systems, Inc.'s (NASDAQ:MMSI) P/E
Dec 18These 4 Measures Indicate That Merit Medical Systems (NASDAQ:MMSI) Is Using Debt Safely
Nov 21What Is Merit Medical Systems, Inc.'s (NASDAQ:MMSI) Share Price Doing?
Nov 06Estimating The Fair Value Of Merit Medical Systems, Inc. (NASDAQ:MMSI)
Oct 23Does Merit Medical Systems (NASDAQ:MMSI) Deserve A Spot On Your Watchlist?
Sep 11Return Trends At Merit Medical Systems (NASDAQ:MMSI) Aren't Appealing
Aug 13Is Now An Opportune Moment To Examine Merit Medical Systems, Inc. (NASDAQ:MMSI)?
Jul 31Is Merit Medical Systems (NASDAQ:MMSI) A Risky Investment?
Jul 17Is Now The Time To Put Merit Medical Systems (NASDAQ:MMSI) On Your Watchlist?
Jun 07Is It Time To Consider Buying Merit Medical Systems, Inc. (NASDAQ:MMSI)?
May 01We Think Merit Medical Systems (NASDAQ:MMSI) Can Manage Its Debt With Ease
Apr 16Returns On Capital At Merit Medical Systems (NASDAQ:MMSI) Have Hit The Brakes
Apr 02Is Now The Time To Put Merit Medical Systems (NASDAQ:MMSI) On Your Watchlist?
Mar 01Merit Medical Systems, Inc.'s (NASDAQ:MMSI) Intrinsic Value Is Potentially 24% Below Its Share Price
Feb 01Is Now The Time To Look At Buying Merit Medical Systems, Inc. (NASDAQ:MMSI)?
Jan 12Merit Medical Systems (NASDAQ:MMSI) Seems To Use Debt Rather Sparingly
Dec 29Here's Why We Think Merit Medical Systems (NASDAQ:MMSI) Is Well Worth Watching
Nov 23Analyse der Geschäftsführervergütung
| Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$117m |
| Mar 31 2024 | n/a | n/a | US$102m |
| Dec 31 2023 | US$10m | US$2m | US$94m |
| Sep 30 2023 | n/a | n/a | US$100m |
| Jun 30 2023 | n/a | n/a | US$90m |
| Mar 31 2023 | n/a | n/a | US$85m |
| Dec 31 2022 | US$8m | US$2m | US$75m |
| Sep 30 2022 | n/a | n/a | US$62m |
| Jun 30 2022 | n/a | n/a | US$58m |
| Mar 31 2022 | n/a | n/a | US$48m |
| Dec 31 2021 | US$8m | US$2m | US$48m |
| Sep 30 2021 | n/a | n/a | US$43m |
| Jun 30 2021 | n/a | n/a | US$28m |
| Mar 31 2021 | n/a | n/a | US$4m |
| Dec 31 2020 | US$8m | US$2m | -US$10m |
| Sep 30 2020 | n/a | n/a | -US$29m |
| Jun 30 2020 | n/a | n/a | -US$30m |
| Mar 31 2020 | n/a | n/a | -US$4m |
| Dec 31 2019 | US$5m | US$2m | US$5m |
| Sep 30 2019 | n/a | n/a | US$19m |
| Jun 30 2019 | n/a | n/a | US$39m |
| Mar 31 2019 | n/a | n/a | US$43m |
| Dec 31 2018 | US$4m | US$2m | US$42m |
| Sep 30 2018 | n/a | n/a | US$40m |
| Jun 30 2018 | n/a | n/a | US$19m |
| Mar 31 2018 | n/a | n/a | US$18m |
| Dec 31 2017 | US$4m | US$1m | US$28m |
Vergütung im Vergleich zum Markt: FredDie Gesamtvergütung ($USD10.05M) liegt im Durchschnitt der Unternehmen ähnlicher Größe auf dem Markt US ($USD8.45M).
Entschädigung vs. Einkommen: FredDie Bezüge der Mitarbeiter sind im vergangenen Jahr um mehr als 20 % gestiegen.
Geschäftsführer
Fred Lampropoulos (74 yo)
37.2yrs
Amtszeit
US$10,052,664
Vergütung
Mr. Fred P. Lampropoulos has been the President of BioSphere Medical, Inc. since September 2010. He is Founder of Merit Medical Systems, Inc. and has been its Chairman and Chief Executive Officer since Jul...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| Founder | 37.2yrs | US$10.05m | 1.98% $ 112.3m | |
| President | less than a year | US$2.81m | 0.060% $ 3.4m | |
| CFO & Treasurer | 6.3yrs | US$2.77m | 0.013% $ 728.4k | |
| Chief Operating Officer | 2.4yrs | US$2.71m | 0.025% $ 1.4m | |
| Chief Legal Officer & Corporate Secretary | 8.4yrs | US$2.66m | 0.030% $ 1.7m | |
| Chief Information Officer | 1.7yrs | keine Daten | keine Daten | |
| Vice President of Global Communications | no data | keine Daten | keine Daten | |
| Executive Vice President of Global Marketing & Strategy | no data | keine Daten | keine Daten | |
| Chief Human Resources Officer | 3.8yrs | keine Daten | keine Daten | |
| Chief Regulatory Affairs Officer | 11.7yrs | keine Daten | keine Daten | |
| Managing Director of Operation Merit Medical Tijuana | no data | keine Daten | keine Daten | |
| Executive Vice President of Merit Medical EMEA | no data | keine Daten | keine Daten |
5.0yrs
Durchschnittliche Betriebszugehörigkeit
55.5yo
Durchschnittliches Alter
Erfahrenes Management: MMSIDas Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (5 ).
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| Founder | 37.2yrs | US$10.05m | 1.98% $ 112.3m | |
| Independent Director | 2.3yrs | US$275.99k | 0.0052% $ 297.9k | |
| Lead Independent Director | 9.2yrs | US$320.99k | 0.051% $ 2.9m | |
| Independent Director | 7.3yrs | US$290.99k | 0.029% $ 1.7m | |
| Independent Director | 4.3yrs | US$290.99k | 0.018% $ 1.0m | |
| Independent Director | 5.1yrs | US$295.99k | 0.010% $ 582.8k | |
| Independent Director | 3.3yrs | US$275.99k | 0.0081% $ 458.3k | |
| Independent Director | less than a year | keine Daten | keine Daten |
4.7yrs
Durchschnittliche Betriebszugehörigkeit
63.5yo
Durchschnittliches Alter
Erfahrener Vorstand: MMSIDie Vorstandsmitglieder gelten als erfahren (4 Jahre durchschnittliche Amtszeit).